Evidence map›Paper›PMID 29152080›Full record

ArticleOncotarget2017

Vincristine liposomes with smaller particle size have stronger diffusion ability in tumor and improve tumor accumulation of vincristine significantly.

Siyu Ma, Mingyuan Li, Nan Liu, Ying Li, Zhiping Li, Yang Yang, Fanglin Yu, Xiaoqin Hu, Cheng Liu, Xingguo Mei

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Siyu Ma *Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, PR China.
Mingyuan Li *Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, PR China.
Nan LiuInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, PR China.
Ying LiInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, PR China.
Zhiping LiInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, PR China.
Yang YangInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, PR China.
Fanglin YuInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, PR China.
Xiaoqin HuInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, PR China.
Cheng LiuInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, PR China.
Xingguo MeiInstitute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, PR China.
Academy of Military Medical Sciences · CNWuhan Institute of Technology · CNChina International Science and Technology Cooperation · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The passive targeting is the premise of active targeting that could make nanocarrier detained in tumor tissue. The particle size is the most important factor that influences the diffusion and distribution of nanoparticle both

Indexed as

diffusion abilityliposomeparticle sizetargeting effecttumor targeting

Identifiers

PMID29152080
PMCPMC5675632
OpenAlexW2744322882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.